How much cash does Lifecore Biomedical, Inc. generate?

Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.

What is Lifecore Biomedical, Inc.'s free cash flow?

After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.

Where does Lifecore Biomedical, Inc.'s cash flow data come from?

Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Lifecore Biomedical, Inc. LFCR Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25	TTM Q4 '24
Net income	-$38.72M—	——	——	——	——
Depreciation and amortization	$8.03M+0.9%	$8.13M-5.6%	$8.06M-17.9%	$7.78M-29.2%	$7.95M-39.6%
Stock-based compensation	$10.16M+63.8%	$9.94M+83.4%	$8.88M+83.9%	$7.09M+62.5%	$6.2M+71.7%
Gain (loss) on sale of assets	——	——	——	——	——
Change in inventories	-$7.69M—	——	——	——	——
Change in accounts payable	——	——	——	$1.15M-90.1%	-$6.68M-141%
Change in accrued liabilities	-$4.81M-391%	$4.53M+167%	$898K—	$1.01M—	$1.65M—
Change in other assets	-$378K+86.9%	$366K+107%	$269K+105%	-$5.11M-988%	-$2.89M-34.2%
Other working capital changes	——	——	——	-$1.71M—	-$1.83M—
Change in receivables	$2.26M—	$1.15M—	——	——	——
Net cash from operating activities	——	$3.16M+129%	$545K+103%	$7.97M+132%	$257K+101%
Capital expenditures	$13.42M-27.1%	$14.03M—	$14.94M—	$16.76M—	$18.4M—
Proceeds from sale of property, plant and equipment	——	——	——	——	——
Net cash from investing activities	-$6.42M+65.1%	-$7.03M+67.8%	-$14.94M-48.6%	-$16.76M-73.9%	-$18.4M-282%
Repayments of debt	——	——	——	$29.91M-75.8%	$0-100%
Taxes paid for net share settlement	$1.27M+736%	$1.16M+1,073%	$1.07M+776%	$696K+176%	$152K-44.5%
Net cash from financing activities	$6.83M—	——	——	——	——
Net increase (decrease) in cash	——	——	——	——	——
Depreciation	——	——	——	——	——
Gain (Loss) on Disposition of Other Assets	——	——	——	——	-$18K—
Gain on termination of lease	$2.64M—	$1.98M—	$1.32M—	$660.5K—	$0—
Accrued expenses and other liabilities	-$5.92M—	$3.42M—	——	——	——
Increase (Decrease) in Contract with Customer, Asset	$2.91M—	$1.42M—	——	——	——
Increase (Decrease) in Other Operating Assets	-$378K+86.9%	$366K+114%	$269K+109%	-$5.11M-731%	-$2.89M-34.2%
Other Noncash Income (Expense)	——	——	——	-$1.71M—	-$1.83M—
Payment-in-kind interest	——	——	——	$17.14M—	$15.44M—
Gain (loss) on mark-to-market of Escrowed Shares	——	$1.5M-96.4%	$23.1M+10.5%	$42.6M+21,200%	$41.9M—
Proceeds from disposals of property, plant and equipment	——	——	——	——	——
Other, net	——	——	——	——	——
Repayments of Long-Term Lines of Credit	——	——	——	$139.94M—	$146.7M—
Proceeds From Long Term Lines Of Credit	——	——	——	$144.01M—	$149.59M—
Free cash flow	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Lifecore Biomedical, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Lifecore Biomedical, Inc. generate?: Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.
What is Lifecore Biomedical, Inc.'s free cash flow?: After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.
Where does Lifecore Biomedical, Inc.'s cash flow data come from?: Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.